189 related articles for article (PubMed ID: 10602517)
21. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
22. Distinct regions of allelic loss on 13q in prostate cancer.
Cooney KA; Wetzel JC; Merajver SD; Macoska JA; Singleton TP; Wojno KJ
Cancer Res; 1996 Mar; 56(5):1142-5. PubMed ID: 8640774
[TBL] [Abstract][Full Text] [Related]
23. Localization of a novel tumor suppressor gene associated with human oral cancer on chromosome 4q25.
Wang XL; Uzawa K; Imai FL; Tanzawa H
Oncogene; 1999 Jan; 18(3):823-5. PubMed ID: 9989834
[TBL] [Abstract][Full Text] [Related]
24. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade.
Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G
Clin Cancer Res; 2000 Feb; 6(2):610-5. PubMed ID: 10690546
[TBL] [Abstract][Full Text] [Related]
25. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
[TBL] [Abstract][Full Text] [Related]
26. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
28. Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.
Goodarzi G; Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Pai SK; Hirota S; Hosobe S; Miura K; Bandyopadhyay S; Gross SC; Balaji KC; Watabe K
Genes Chromosomes Cancer; 2001 Sep; 32(1):33-42. PubMed ID: 11477659
[TBL] [Abstract][Full Text] [Related]
29. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer.
Elo JP; Härkönen P; Kyllönen AP; Lukkarinen O; Poutanen M; Vihko R; Vihko P
Cancer Res; 1997 Aug; 57(16):3356-9. PubMed ID: 9269995
[TBL] [Abstract][Full Text] [Related]
31. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
Wu YQ; Chen H; Rubin MA; Wojno KJ; Cooney KA
Cancer Res; 2001 Dec; 61(24):8651-3. PubMed ID: 11751379
[TBL] [Abstract][Full Text] [Related]
34. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
35. Molecular studies of loss of heterozygosity in Chinese sporadic retinoblastoma patients.
Zhang XL; Fu WL; Zhao HX; Zhou LX; Huang JF; Wang JH
Clin Chim Acta; 2005 Aug; 358(1-2):75-80. PubMed ID: 15921673
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
Ittmann MM
Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
[TBL] [Abstract][Full Text] [Related]
37. Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer.
Nakanishi H; Wang XL; Imai FL; Kato J; Shiiba M; Miya T; Imai Y; Tanzawa H
Anticancer Res; 1999; 19(1A):29-34. PubMed ID: 10226521
[TBL] [Abstract][Full Text] [Related]
38. Identification of two distinct deleted regions on chromosome 13 in prostate cancer.
Li C; Larsson C; Futreal A; Lancaster J; Phelan C; Aspenblad U; Sundelin B; Liu Y; Ekman P; Auer G; Bergerheim US
Oncogene; 1998 Jan; 16(4):481-7. PubMed ID: 9484837
[TBL] [Abstract][Full Text] [Related]
39. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers.
Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J
Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204
[TBL] [Abstract][Full Text] [Related]
40. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
